Integration of effect biomarkers in human biomonitoring

Bibliographic Details
Main Author: Ladeira, Carina
Publication Date: 2024
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10400.21/17640
Summary: Human biomonitoring is an important tool for assessing exposure to chemicals and their health risks. Once human internal exposure to a chemical is shown, the complementary use of effect biomarkers can help bridge health consequences by providing data on pre-clinical manifestations of disease with a probability of being prevented. Effect biomarkers that measure genetic damage are potent tools to address the carcinogenic and/or mutagenic potential of chemical exposures, increasing confidence in regulatory risk assessment decision-making processes. The micronucleus (MN) test is recognized as one of the most successful and reliable assays to assess genotoxic events, which are associated with exposures that may cause cancer. There is fair evidence of a significant increase in MN frequency in patients with cancer and other chronic diseases compared with controls, substantiating its predictive value. Promising approaches, such as combined effect biomarkers open the possibility to evaluate the combined effects of complex chemical mixtures in human samples, and efforts are needed to integrate these approaches in risk assessment. Although effect biomarkers are gaining ground in human biomonitoring, new challenges are still arising. To move towards the next generation of human risk assessment is crucial to establish bridges between standard approaches of effect biomarkers and new approach methods (NAMs) and tools for increasing the mechanistically-based biological plausibility in human studies, such as the adverse outcome pathways (AOPs) framework. Human epidemiological studies with biomarkers of effect play an invaluable role in identifying the health effects of chemical exposures and may provide a tool for improving risk assessment and may be especially useful in the case of risk assessment of chemical mixtures.
id RCAP_213c9c67d9420db7110d314fb2d36d48
oai_identifier_str oai:repositorio.ipl.pt:10400.21/17640
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Integration of effect biomarkers in human biomonitoringOccupational healthOccupational exposureHuman biomonitoringEffect biomarkersIPL/2021/PLASCOGEN_ESTeSLFCT_UIDP/05608/2020FCT_UIDB/05608/2020Human biomonitoring is an important tool for assessing exposure to chemicals and their health risks. Once human internal exposure to a chemical is shown, the complementary use of effect biomarkers can help bridge health consequences by providing data on pre-clinical manifestations of disease with a probability of being prevented. Effect biomarkers that measure genetic damage are potent tools to address the carcinogenic and/or mutagenic potential of chemical exposures, increasing confidence in regulatory risk assessment decision-making processes. The micronucleus (MN) test is recognized as one of the most successful and reliable assays to assess genotoxic events, which are associated with exposures that may cause cancer. There is fair evidence of a significant increase in MN frequency in patients with cancer and other chronic diseases compared with controls, substantiating its predictive value. Promising approaches, such as combined effect biomarkers open the possibility to evaluate the combined effects of complex chemical mixtures in human samples, and efforts are needed to integrate these approaches in risk assessment. Although effect biomarkers are gaining ground in human biomonitoring, new challenges are still arising. To move towards the next generation of human risk assessment is crucial to establish bridges between standard approaches of effect biomarkers and new approach methods (NAMs) and tools for increasing the mechanistically-based biological plausibility in human studies, such as the adverse outcome pathways (AOPs) framework. Human epidemiological studies with biomarkers of effect play an invaluable role in identifying the health effects of chemical exposures and may provide a tool for improving risk assessment and may be especially useful in the case of risk assessment of chemical mixtures.RCIPLLadeira, Carina2024-08-29T11:33:15Z2024-062024-06-01T00:00:00Zconference objectinfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10400.21/17640enginfo:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2025-02-12T10:07:45Zoai:repositorio.ipl.pt:10400.21/17640Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T20:04:19.971148Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Integration of effect biomarkers in human biomonitoring
title Integration of effect biomarkers in human biomonitoring
spellingShingle Integration of effect biomarkers in human biomonitoring
Ladeira, Carina
Occupational health
Occupational exposure
Human biomonitoring
Effect biomarkers
IPL/2021/PLASCOGEN_ESTeSL
FCT_UIDP/05608/2020
FCT_UIDB/05608/2020
title_short Integration of effect biomarkers in human biomonitoring
title_full Integration of effect biomarkers in human biomonitoring
title_fullStr Integration of effect biomarkers in human biomonitoring
title_full_unstemmed Integration of effect biomarkers in human biomonitoring
title_sort Integration of effect biomarkers in human biomonitoring
author Ladeira, Carina
author_facet Ladeira, Carina
author_role author
dc.contributor.none.fl_str_mv RCIPL
dc.contributor.author.fl_str_mv Ladeira, Carina
dc.subject.por.fl_str_mv Occupational health
Occupational exposure
Human biomonitoring
Effect biomarkers
IPL/2021/PLASCOGEN_ESTeSL
FCT_UIDP/05608/2020
FCT_UIDB/05608/2020
topic Occupational health
Occupational exposure
Human biomonitoring
Effect biomarkers
IPL/2021/PLASCOGEN_ESTeSL
FCT_UIDP/05608/2020
FCT_UIDB/05608/2020
description Human biomonitoring is an important tool for assessing exposure to chemicals and their health risks. Once human internal exposure to a chemical is shown, the complementary use of effect biomarkers can help bridge health consequences by providing data on pre-clinical manifestations of disease with a probability of being prevented. Effect biomarkers that measure genetic damage are potent tools to address the carcinogenic and/or mutagenic potential of chemical exposures, increasing confidence in regulatory risk assessment decision-making processes. The micronucleus (MN) test is recognized as one of the most successful and reliable assays to assess genotoxic events, which are associated with exposures that may cause cancer. There is fair evidence of a significant increase in MN frequency in patients with cancer and other chronic diseases compared with controls, substantiating its predictive value. Promising approaches, such as combined effect biomarkers open the possibility to evaluate the combined effects of complex chemical mixtures in human samples, and efforts are needed to integrate these approaches in risk assessment. Although effect biomarkers are gaining ground in human biomonitoring, new challenges are still arising. To move towards the next generation of human risk assessment is crucial to establish bridges between standard approaches of effect biomarkers and new approach methods (NAMs) and tools for increasing the mechanistically-based biological plausibility in human studies, such as the adverse outcome pathways (AOPs) framework. Human epidemiological studies with biomarkers of effect play an invaluable role in identifying the health effects of chemical exposures and may provide a tool for improving risk assessment and may be especially useful in the case of risk assessment of chemical mixtures.
publishDate 2024
dc.date.none.fl_str_mv 2024-08-29T11:33:15Z
2024-06
2024-06-01T00:00:00Z
dc.type.driver.fl_str_mv conference object
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.21/17640
url http://hdl.handle.net/10400.21/17640
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833598476095586304